M&A Deal Summary |
|
|---|---|
| Date | 2007-06-11 |
| Target | Grandix Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Strides Pharma Science |
| Deal Type | Add-on Acquisition |
| Deal Value | 24M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1990 |
| Sector | Life Science |
| Employees | 3,301 |
| Revenue | 43.9B INR (2025) |
Strides Pharma Science is a pharmaceutical company. Strides operates in pharma generics, branded generics, and biopharma. Strides Pharma Science was founded in 1990 and is based in Bangalore, Karnataka.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: India M&A | 1 of 1 |
| Year: 2007 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-24 |
Ascent Pharmahealth
Melbourne, Australia Ascent Pharmahealth Ltd, markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market. |
Sell | AU$375M |
